Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Kitzmiller
J L
JL
Main
E
E
Ward
B
B
Theiss
T
T
Peterson
D L
DL
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061268:Insulin Lispro; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy* / Q000503:physiopathology*
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro